Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (loss) $ 766,643 $ (67,736)
Adjustments to reconcile net income to cash used in operating activities:    
Depreciation and amortization 400,820 382,912
Allowance for bad debt 562,005 504,350
Stock based compensation 272,868 325,021
Gain on sale of equipment (17,400)
Changes in operating assets and liabilities:    
Accounts receivable (2,313,977) (1,823,255)
Prepaid expenses and other current assets (154,907) (98,287)
Employee loans (324,143) (345,591)
Other assets (55,625)
Accounts payable and accrued expenses 380,350 138,085
Income taxes payable 24,754
Deferred rent 42,420 103,743
Unearned income (16,995) 17,101
Net cash used in operating activities (433,187) (863,657)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of equipment 17,400
Purchase of Crane Creek Surgical Center (400,000)
Purchase of equipment (381,806) (197,588)
Net cash used in investing activities (764,406) (197,588)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock 7,500,000
Proceeds from notes payable 120,754 22,113
Purchase of treasury stock (49,954)
Payments on notes payable (27,167) (262,546)
Net cash provided by (used in) financing activities 7,593,587 (290,387)
Net increase (decrease) in cash 6,395,994 (1,351,632)
Cash, beginning of period 2,015,534 4,593,638
Cash, end of period 8,411,528 3,242,006
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Cash paid during the period for interest $ 57,733 $ 62,181